Keyword Suggestion
Domain Informations
Adcetris.com lookup results from whois.comlaude.com server:
- Domain created: 2010-01-12T17:29:18Z
- Domain updated: 2024-08-26T04:22:00Z
- Domain expires: 2026-01-12T17:29:18Z 1 Year, 114 Days left
- Website age: 14 Years, 250 Days
- Registrar Domain ID: 1581606179_DOMAIN_COM-VRSN
- Registrar Url: http://www.comlaude.com
- Registrar WHOIS Server: whois.comlaude.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +442074218250
- Name server:
- NS1-07.AZURE-DNS.COM
- NS2-07.AZURE-DNS.NET
- NS3-07.AZURE-DNS.ORG
- NS4-07.AZURE-DNS.INFO
Network
- inetnum : 13.64.0.0 - 13.107.255.255
- name : MSFT
- handle : NET-13-64-0-0-1
- status : Direct Allocation
- created : 1998-07-10
- changed : 2024-03-18
- desc : To report suspected security issues specific to traffic emanating from Microsoft online services, including the distribution of malicious content or other illicit or illegal material through a Microsoft online service, please submit reports to:,* https://cert.microsoft.com.,For SPAM and other abuse issues, such as Microsoft Accounts, please contact:,* [email protected].,To report security vulnerabilities in Microsoft products and services, please contact:,* [email protected].,For legal and law enforcement-related requests, please contact:,* [email protected],For routing, peering or DNS issues, please,contact:,* [email protected]
Owner
- organization : Microsoft Corporation
- handle : MSFT
- address : Array,Redmond,WA,98052,US
Technical support
- handle : SINGH683-ARIN
- name : Singh, Prachi
- phone : +1-425-707-5601
- email : [email protected]
Abuse
- handle : MAC74-ARIN
- name : Microsoft Abuse Contact
- phone : +1-425-882-8080
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 286730 |
namecheap.com | 101387 |
networksolutions.com | 69118 |
tucows.com | 52617 |
publicdomainregistry.com | 39120 |
whois.godaddy.com | 32793 |
enomdomains.com | 23825 |
namesilo.com | 21429 |
domains.google.com | 21384 |
cloudflare.com | 20573 |
gmo.jp | 18110 |
name.com | 17601 |
fastdomain.com | 14708 |
register.com | 13495 |
net.cn | 12481 |
ionos.com | 12416 |
ovh.com | 12416 |
gandi.net | 12305 |
registrar.amazon.com | 12111 |
Host Informations
- IP address: 13.107.246.41
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 13.107.246.41)
Spam Check (IP: 13.107.246.41)
Recent Searched Sites
› Plc.vic.edu.au (17 seconds ago) / US
› Theuncoolhunter.com (8 seconds ago) / US
› Lasteufopark.ee (17 seconds ago) / EE
› Cdek.shopping (21 seconds ago) / US
› Cdn.bolshoyvopros.ru (17 seconds ago) / DE
› Seawideb2b.com (3 seconds ago) / US
› Nicolebremner.com (28 seconds ago) / US
› Skbit4.net (14 seconds ago) / US
› Blog.privnote.com (7 seconds ago) / CA
› Ywambelt.org (16 seconds ago) / US
› Offthehookyachts.com (10 seconds ago) / US
› 209.43.25.180 (2 seconds ago) / US
› Unisyn.io (3 seconds ago) /
› Electroshield.ru (2 seconds ago) / RU
› Joxconsulting.com (10 seconds ago) / US
› Adcetris.com (1 seconds ago) / US
› Urdubiz.com (9 seconds ago) / AU
› Startupchile.org (8 seconds ago) / US
› Strukmyer.com (9 seconds ago) / US
› Ventav.com.tr (5 seconds ago) / US
Websites Listing
We found Websites Listing below when search with adcetris.com on Search Engine
Location and contact information – Seagen Canada
ADCETRIS ® (brentuximab ... Telephone: 1-833-944-6546 Email: [email protected]. For medical information contact 1-833-4SEAGEN (1-833-473-2436) [email protected]. This website is intended for Canadian residents only. ...
Seagen.caContact Seattle Genetics Inc.
Patients on ADCETRIS for any new signs or symptoms that may be suggestive of PML. Further treatment with ADCETRIS should be withheld immediately at the first sign or symptom suggestive of PML. Dosage and Administration The recommended dose is 1.8 mg/kg administered only as an intravenous infusion over 30 minutes every 3 weeks. The dose for patients weighing greater …
Canada.caFirst-Line Stage III or IV cHL - ADCETRIS® (brentuximab ...
Dosage in ECHELON-1. Study treatment was administered intravenously on Days 1 and 15 of each 28-day cycle for up to 6 cycles. A+AVD (ADCETRIS ® [brentuximab vedotin] 1.2 mg/kg, doxorubicin 25 mg/m 2, vinblastine 6 mg/m 2, dacarbazine 375 mg/m 2) or ABVD (doxorubicin 25 mg/m 2, bleomycin 10 units/m 2, vinblastine 6 mg/m 2, dacarbazine 375 mg/m 2). 1. Median …
Adcetrispro.comGlobal Conjugated Monoclonal Antibodies Markets Report
1 day ago · Contact Data CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For ...
Globenewswire.comSeagen hiring Market Development Manager ADCETRIS in ...
Summary. Seagen is looking for a Market Development Manager (MDM) to support the ADCETRIS brand team. The MDM is an exceptional leader who will work to drive results in three main areas: (1 ...
Linkedin.comLocations and Contact Information – Seagen
2000 Argentia Road. Plaza 3, Suite 400. Mississauga, ON L5N 1V9. 1-833-4SEAGEN (1-833-473-2436) [email protected].
Seagen.comSeagen hiring Division Manager ADCETRIS Florida in Tampa ...
The Division Manager (ADCETRIS) will be accountable for attaining sales forecast goals across all territories included in the Florida division. They will lead a team of high-performing Sales ...
Linkedin.comSeattle Genetics and Takeda Announce Positive Results from ...
2018-10-01 · The safety profile of ADCETRIS plus CHP in the ECHELON-2 trial was comparable to CHOP and consistent with the established safety profile of ADCETRIS in combination with chemotherapy. Additional data will be presented at the American Society of Hematology (ASH) 2018 annual meeting, December 1-4, 2018, in San Diego, California.
Financialpost.comSeagen Inc (SGEN-Q) Quote - Press Release - The Globe and Mail
2017-11-09 · ADCETRIS is an ADC comprising an anti-CD30 monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent, monomethyl auristatin E (MMAE), utilizing Seattle Genetics ...
Theglobeandmail.comSeagen annuncia i risultati preliminari derivati dalla ...
2021-12-13 · Seagen annuncia i risultati preliminari derivati dalla sperimentazione clinica di fase 2 condotta su ADCETRIS ® (brentuximab vedotin) in una nuova combinazione di agenti per il trattamento di ...
Ansa.it
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
cutoutiltools.com | enomdomains.com | -2 Years, -25 Days |
mybeaconhome.com | godaddy.com | -1 Years, -236 Days |
yumealz.com | godaddy.com | -1 Years, -258 Days |
oneplacecapital.com | networksolutions.com | -2 Years, -81 Days |
aswatchgallery.com | joker.com | 94 Days |
chrysbio.com | tucows.com | -2 Years, -154 Days |
montereydesigncenter.com | fastdomain.com | -2 Years, -122 Days |
comicbookrevolution.com | namesilo.com | 1 Year, 212 Days |
gmhba.org | gandi.net | 2 Years, 61 Days |
ccbmn.com | gname.com | -1 Years, -165 Days |